Pregabalin (CAS 148553-50-8) -4-methyl-pregabalin

Pregabalin (CAS 148553-50-8) is a high-purity pharmaceutical API with a well-defined molecular structure, acting as a potent anticonvulsant and neuropathic pain reliever. Its core mechanism targets voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters to alleviate seizures and neuropathic discomfort. This premium API exhibits excellent solubility and bioavailability, ensuring consistent performance in various formulations including capsules, tablets, and oral solutions, with minimal drug-drug interaction risks for enhanced clinical safety.

It caters to the critical needs of pharmaceutical manufacturers, research laboratories, and clinical supply chains, widely applied in treating partial-onset seizures in adults, diabetic peripheral neuropathy, postherpetic neuralgia, and generalized anxiety disorder. Produced under strict GMP guidelines, every batch undergoes rigorous purity and potency testing to meet international pharmacopoeia standards. For businesses prioritizing reliability, efficacy, and regulatory compliance, this Pregabalin API serves as a cornerstone raw material for developing high-quality central nervous system medications that address unmet clinical needs.